CEACAM5 Antikörper
Kurzübersicht für CEACAM5 Antikörper (ABIN319989)
Target
Alle CEACAM5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- This antibody recognises human carcinoembryonic antigen. The antibody does not cross-react with normal cross-reacting antigen (NCA), or with biliary glycoprotein (BGP).
-
Aufreinigung
- Affinity Chromatography on Protein G.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
ELISA. Flow Cytometry. Immunohistochemistry on Frozen and Paraffin Embedded Sections (1/1000): Requires protein digestion pre-treatment of Paraffin sections
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS buffer, pH 7.4 with 0.09 % Sodium Azide as preservative.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
-
- CEACAM5 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5))
-
Andere Bezeichnung
- CD66e / CEACAM5
-
Hintergrund
- Carcino Embryonic Antigen (CEA) is synthesised during development in the fetal gut, and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibodies to CEA are useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60 to 70 % are CEA+) from pleural mesotheliomas (rarely or weakly CEA+).Synonyms: CEA, Carcinoembryonic antigen, Carcinoembryonic antigen-related cell adhesion molecule 5, Meconium antigen 100
-
Gen-ID
- 1048
-
NCBI Accession
- NP_004354
-
UniProt
- P06731
Target
-